share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director Hannan Kathy Hopinkah

SEC announcement ·  Jun 15 04:31
Summary by Futu AI
Kathy Hopinkah Hannan, associated with Ginkgo Bioworks Holdings, Inc., executed a significant stock transaction on June 12, 2024. Hannan acquired 105,263 shares of Ginkgo Bioworks' Class A Common Stock through the exercise or conversion of derivative securities. Following this transaction, Hannan's direct holdings in the company amount to a total of 167,249 shares. The transaction reflects a notable change in Hannan's investment in the company, and it could be of interest to investors monitoring insider activity within Ginkgo Bioworks.
Kathy Hopinkah Hannan, associated with Ginkgo Bioworks Holdings, Inc., executed a significant stock transaction on June 12, 2024. Hannan acquired 105,263 shares of Ginkgo Bioworks' Class A Common Stock through the exercise or conversion of derivative securities. Following this transaction, Hannan's direct holdings in the company amount to a total of 167,249 shares. The transaction reflects a notable change in Hannan's investment in the company, and it could be of interest to investors monitoring insider activity within Ginkgo Bioworks.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.